Cargando…
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features
IMPORTANCE: The optimal management strategy for high-risk prostate cancer and additional adverse clinicopathologic features remains unknown. OBJECTIVE: To compare clinical outcomes among patients with high-risk prostate cancer after definitive treatment. DESIGN, SETTING, AND PARTICIPANTS: This retro...
Ejemplares similares
-
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
por: Xiang, Michael, et al.
Publicado: (2021) -
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts
por: Kishan, Amar U., et al.
Publicado: (2022) -
Quantifying the Ki-67 Heterogeneity Profile in Prostate Cancer
por: Mesko, Shane, et al.
Publicado: (2013) -
Single-fraction Stereotactic Body Radiation Therapy versus Conventionally Fractionated Radiation Therapy for the Treatment of Prostate Cancer Bone Metastases
por: Gao, Robert W., et al.
Publicado: (2019) -
Biomarkers in active surveillance
por: Loeb, Stacy, et al.
Publicado: (2018)